Outpatient parenteral antimicrobial therapy (OPAT): Is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 2, 2007, Pages 356-362

  Matthews, Philippa C ^a,b   Conlon, Christopher P ^a   Berendt, Anthony R ^a,b   Kayley, Jill ^c   Jefferies, Lorrayne ^d   Atkins, Bridget L ^a,b   Byren, Ivor ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c The Pavilion   (United Kingdom)

^d Oxfordshire Primary Care Trust   (United Kingdom)

Author keywords

Complications; H OPAT; Home intravenous therapy; S OPAT; Self administration

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; ERTAPENEM; GENTAMICIN; GLYCOPEPTIDE; MEROPENEM; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL ARTHRITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SELF ADMINISTRATION; ENDOCARDITIS; FEASIBILITY STUDY; FEMALE; GRAFT INFECTION; HEALTH CARE PERSONNEL; HOME CARE; HOME INTRAVENOUS THERAPY; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; OUTPATIENT CARE; PATIENT SAFETY; PATIENT SELECTION; PROSTHESIS INFECTION; RETROSPECTIVE STUDY; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; VASCULAR ACCESS DEVICE;

ADULT; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; CATHETERS, INDWELLING; COHORT STUDIES; DATA COLLECTION; FEMALE; HOME INFUSION THERAPY; HUMANS; INFECTION; INFUSIONS, PARENTERAL; MALE; OUTPATIENTS; RETROSPECTIVE STUDIES;

EID: 34547828227     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm210     Document Type: Article

References (36)

1. Tice AD, Rehm SJ, Dalovisio JR et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004; 38: 1651-72.
2. Nathwani D, Tice A. Ambulatory antimicrobial use: The value of an outcomes registry. J Antimicrob Chemother 2002; 49: 149-54.
3. Kayley J, Berendt AR, Snelling MJ et al. Safe intravenous antibiotic therapy at home: Experience of a UK based programme. J Antimicrob Chemother 1996; 37: 1023-9.
4. Goodfellow AF, Wai AO, Frighetto L et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother 2002; 36: 1851-5.
5. Parker SE, Nathwani D, O'Reilly D et al. Evaluation of the impact of non-inpatient i.v. antibiotic treatment for acute infections on the hospital, primary care services and the patent. J Antimicrob Chemother 1998; 42: 373-80.
6. Seaton RA, Bell E, Gourlay Y et al. Nurse-led management of uncomplicated cellulitis in the community: Evaluation of a protocol incorporating intravenous ceftriaxone. J Antimicrob Chemother 2005; 55: 764-7.
7. Conlon CP, Kayley J, Lalloo DG et al. Intravenous antibiotic treatment at home can provide higher quality care. BMJ 1997; 314: 1551.
8. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003; 51: 1261-8.
9. Upton A, Ellis-Pegler RB, Woodhouse A. Outpatient Parenteral Antimicrobial Therapy (OPAT): A review of experience at Auckland Hospital. N Z Med J 2004; 117: U1020.
10. Ruebner R, Karen R, Coffin S et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics 2006; 117: 1210-5.
11. Graham DR, Keldermans MM, Klemm LW et al. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 1991; 91 Suppl 3B: 95S-100S.
12. Tice A. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: Data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries. Chemotherapy 2001; 47 Suppl 1: 5-16.
13. Wiselka MJ, Nicholson KG. Outpatient parenteral antimicrobial therapy: experience in a large teaching hospital. J Infect 1997; 35: 73-6.
14. Esposito S. Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages. Drugs 2000; 59 Suppl 3: 19-28; discussion 47-9.
15. Kind AC, Williams DN, Persons G et al. Intravenous antibiotic therapy at home. Arch Intern Med 1979; 139: 413-5.
16. Poretz DM, Eron LJ, Goldenberg RI et al. Intravenous antibiotic therapy in an outpatient setting. JAMA 1982; 248: 336-9.
17. Rehm SJ, Weinstein AJ. Home intravenous antibiotic therapy: A team approach. Ann Intern Med 1983; 99: 388-92.
18. Davis JS. Management of bone and joint infections due to Staphylocoocus aureus. Intern Med J 2005; 35 Suppl 2: S79-96.
19. Moran E, Masters S, Berendt AR et al. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007 [Epub ahead of print 5 March 2007].
20. Kowalski TJ, Berbari EF, Huddleston PM et al. The management and outcome of spinal implant infections: Contemporary retrospective cohort study. Clin Infect Dis 2007; 44: 913-20.
21. Bernard L, EI H, Pron B et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: Evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 2001; 26: 445-51.
22. Galperine T, Ader F, Piriou P et al. Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections. Med Mal Infect 2006; 36: 132-7.
23. Nathwani D. The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy 2001; 47 Suppl 1: 17-23.
24. Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: A cohort study in Oxfordshire 1997-2003. BMJ 2005; 331: 992.
25. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia. in the UK. J Antimicrob Chemother 2005; 56 455-62.
26. Pea F, Brollo L, Viale, P et al. Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother 2003; 51: 971-5.
27. Wynn M, Dalovisio JR, Tice AD et al. Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus. South Med J 2005; 98: 590-5.
28. Funk D, Gray J, Plourde PJ. Two-year trends of peripherally inserted central catheter-line complications at a tertiary-care hospital: Role of nursing expertise. Infect Control Hosp Epidemiol 2001; 22: 377-9.
29. Moureau N, Poole S, Murdock MA et al. Central various catheters in home infusion care: Outcomes analysis in 50,470 patients. J Vasc Interv Radiol 2002; 13: 1009-16.
30. Smith JR, Friedell ML, Cheatham ML et al. Peripherally inserted central catheters revisited. Am J Surg 1998; 176: 208-11.
31. Nolet BR. Patient selection in outpatient parenteral antimicrobial therapy. Infect Dis Clin North Am 1998; 12: 835-47.
32. Brown RB. Selection and training of patients for outpatient intravenous-antibiotic therapy. Rev Infect Dis 1991; 13 Suppl 2: S147-51.
33. Tice AD. An office model of outpatient parenteral antibiotic therapy. Rev Infect Dis 1991; 13 Suppl 2: S184-88.
34. Chemaly RF, de Parres JB, Rehm SJ et al. Various thrombosis associated with peripherally inserted central catheters: A retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis 2002; 34: 1179-83.
35. Gilbert DN, Dworkin RJ, Raber SR et al. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997; 337: 829-38.
36. Wai AO, Frighetto L, Marra CA et al. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics 2000; 18: 451-7.